Personalised hypertension management with accurate blood pressure measurement: much achieved, much more to do

It is more than 20 years since the first non-invasive central blood pressure (BP) device became commercially available. The technology is marketed as distinct from standard brachial cuff automated BP measurement by providing more accurate and personalised hypertension management. Many devices and methods estimate central BP, and thousands of publications generated, yet the clinical value remains equivocal and routine central BP measurement is still not recommended in hypertension guidelines.